US FDA grants Breakthrough Therapy Designation to Pfizer’s Respiratory Syncytial Virus vaccine candidate Read more
Pfizer announces positive results for phase-III trial of Etrasimod in Ulcerative Colitis patients Read more
Pfizer to supply UNICEF up to four million treatment courses of novel COVID-19 oral treatment for LMICs Read more
Evotec receives €3 million payment for Bayer starting phase-II clinical development of DNP programme Read more